Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Bayer AG; Bristol-Myers Squibb; Daiichi-Sankyo/Elil Lilly and Company; Glaxo Smith Kline; Boehringer Ingleherim; Medtronic; Merck/Schering Plough; Pfizer; Portola Pharmaceuticals; Sanofi-Aventis
• Grant Support/Research Contract (Institutional) - Bristol-Myers Squibb; Glaxo Smith Kline; Medtronic; Pfizer; Sanofi-Aventis